David W. Boyer

Companies

• Neurocrine BiosciencesChief Corp. Affairs Officer Feb 9, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX8,722 shares²$1.2M at $136.95Sep 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 14, 2026Sold 826 shares at $157.45 of Neurocrine Biosciences²
• Sep 11, 2026Shares withheld for tax 1,936 shares at $156.22 of Neurocrine Biosciences²
• Sep 11, 2026Granted 3,587 shares of Neurocrine Biosciences²
• May 26, 2026Sold 3,888 shares at $156.64 of Neurocrine Biosciences³
• Feb 13, 2026Shares withheld for tax 5,378 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Granted 9,968 shares of Neurocrine Biosciences⁴
• Feb 13, 2026Shares withheld for tax 978 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Exercised options 1,811 shares of Neurocrine Biosciences⁴
• Feb 13, 2026Shares withheld for tax 832 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Exercised options 1,541 shares of Neurocrine Biosciences⁴
• Feb 12, 2026Shares withheld for tax 864 shares at $123.10 of Neurocrine Biosciences⁴
• Feb 12, 2026Exercised options 1,600 shares of Neurocrine Biosciences⁴
• Jan 31, 2026Shares withheld for tax 1,189 shares at $136.06 of Neurocrine Biosciences⁵
• Jan 31, 2026Exercised options 2,096 shares of Neurocrine Biosciences⁵
• Feb 13, 2025Sold 830 shares at $116.69 of Neurocrine Biosciences⁶
• Feb 13, 2025Exercised options 1,541 shares of Neurocrine Biosciences⁶
• Feb 13, 2025Sold 955 shares at $116.79 of Neurocrine Biosciences⁶
• Feb 13, 2025Exercised options 1,811 shares of Neurocrine Biosciences⁶
• Feb 10, 2025Sold 700 shares at $118.31 of Neurocrine Biosciences⁷
• Feb 8, 2025Exercised options 1,329 shares of Neurocrine Biosciences⁷
• Jan 31, 2025Sold 1,104 shares at $152.94 of Neurocrine Biosciences⁸
• Jan 31, 2025Exercised options 2,096 shares of Neurocrine Biosciences⁸
• Oct 3, 2024Sold 1,295 shares at $113.66 of Neurocrine Biosciences⁹
• Sep 13, 2024Sold 3,461 shares at $121.88 of Neurocrine Biosciences¹⁰
• Feb 13, 2024Sold 856 shares at $133.05 of Neurocrine Biosciences¹¹